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Abstract 
Objective: To analyze osteopontin mRNA expression levels in subjects with periodontitis prior 
to (baseline) and 7, 14, and 28 days following scaling and root planing (SRP). Material and 
Methods: Gingival crevicular fluid was collected as clinical samples from four subjects with 
periodontitis (pocket depth, 4-5 mm) aged 35-54 years old as well as from three healthy subjects 
(controls). The osteopontin mRNA expression levels were measured by quantitative real-time 
polymerase chain reaction. Spearman’s rank correlation between osteopontin levels in gingival 
crevicular fluid and the modified gingival index (MGI) was also performed. Results: The 
Wilcoxon signed-rank test showed no significant difference in osteopontin mRNA expression 
levels between baseline and 28 days following SRP (p=0.068). The Friedman test showed no 
significant difference in osteopontin mRNA expression levels between baseline and following 
SRP (7, 14, or 28 days) (p>0.05). Spearman’s rank correlation showed no significant correlation 
between osteopontin mRNA expression levels and MGI (r=0.087; p=0.749). Conclusion: 
Following SRP of periodontal tissue, there was a decreasing trend in osteopontin mRNA 
expression; however, this finding was not statistically significant. Nevertheless, osteopontin can 
be used as a biomarker to monitor the healing process; however, further studies are required to 
clarify our results. 
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Introduction 
Periodontitis is defined as the chronic inflammation of the supportive periodontal tissue that 
progresses slowly or moderately fast [1,2]. Periodontitis can lead to permanent destruction of both 
soft and hard tissue, thereby leading to tooth loss [3]. Studies have shown that individuals aged 35-
54 have a higher prevalence of periodontitis than those in other age groups [4,5]. 
Plaque bacteria are considered the main etiology of periodontitis; bacteria trigger the host 
immune-inflammatory response, which results in loss of periodontal attachment [6,7]. Inflammation 
of periodontal tissue can be caused by a numerous gram-negative anaerobic organisms, thereby 
inducing the production inflammatory cytokines and mediators, which can cause periodontal tissue 
destruction and bone resorption. Interleukin-1, prostaglandin E2, tumor necrosis factor-α, and 
RANKL can initiate sequences of periodontal tissue destruction; if left without intervention, these 
molecules can induce increased expression of other inflammatory mediators and stimulate advanced 
damage. 
Osteopontin (OPN) is a non-collagenous phosphoprotein found in bone extracellular matrix 
and functions as an inflammatory cytokine. OPN is produced by osteoclasts and is expressed at 
maturation and mineralization of osteoblasts during differentiation, also contributing to the 
resorptive stage [8,9]. Studies have shown that OPN plays an important role in the bone resorption 
process; however, its role in periodontal healing remains to be unclear [10,11]. OPN exists in 
Gingival Crevicular Fluid (GCF) and its levels correlate to increased pocket depth and progression 
of periodontal disease in the group of healthy control and periodontitis patients [8]. 
Moreover, previous research found that OPN levels were higher in advanced periodontal 
disease and comparatively low in healthy patients [12]. This study was held in three groups 
(patients who were periodontally healthy, had gingivitis, and periodontitis patients after scaling and 
root planing therapy and used ELISA (enzyme-linked immunosorbent assay) to estimate the OPN 
level. A systematic review reported that OPN was present during the early phase following implant 
placement and higher level of bone-biomarker was found on 7th, 15th, and 30th day (early stage of 
cellular response) and observed in recruitment of macrophages and lymphocytes [13]. 
Treatment for shallow periodontal pockets of 4-5 mm is still dilemmatic for clinicians [14], 
and this pocket depth is included in stage I and II periodontitis in the new classification of 
periodontal disease by the American Association of Periodontology [7,15]. A few studies have 
concluded that periodontal pockets shallower than 5 mm can be treated with non-surgical therapy; 
however, pockets deeper than 5 mm need surgery for a direct view [16]. One particular study 
concluded that the results of non-surgical treatment are not statistically different to those obtained 
by surgery with respect to mild-moderate periodontitis [14]. Scaling and root planing (SRP) is the 
gold standard in non-surgical periodontal treatment [17,18]. 
An increase in clinical attachment and decreased bleeding on probing (BOP) are considered 
as the main characteristics of periodontal healing [19]. However, the modified gingival index (MGI) 
was proposed as a non-invasive measurement to prevent interruption of pocket healing following 
SRP when probing the site. The MGI score is based on the clinical appearance of inflammation at the 
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site [4,20]. A few studies have observed an association between OPN levels and periodontal disease 
progression [8,12]. 
The present study was planned to use quantitative PCR (polymerase chain reaction) to detect 
OPN mRNA (level of gene expression) during the early stage of cellular response. In the present 
study, OPN mRNA expression levels in the GCF of subjects with periodontitis (pocket depth 4-5 
mm; stage I and II periodontitis based the new classification of periodontal disease [7,15] were 
compared among baseline and 7, 14 [21,22] and 28 [23] days following SRP. Healthy subjects were 
evaluated as a control. The hypothesis of the present study was that there would be a statistical 
difference in OPN mRNA expression levels in the GCF of subjects with periodontitis between 
baseline and 28 days following SRP, and that there would be a correlation between these levels and 
the MGI that could be used as a clinical parameter of periodontal healing. 
 
Material and Methods 
Study Subjects 
A total of seven patients aged 35-54 years old from the Clinic of Periodontology, Faculty of 
Dentistry, Universitas Indonesia Dental Hospital were divided into two groups: those with 
periodontitis (four subjects) and healthy controls (three subjects). Two calibrated operators recorded 
the preliminary periodontal status of the patients, which consisted of periodontal pocket depth and 
BOP score at baseline, and the modified gingival index (MGI) at baseline and following treatment. 
Subjects with rapid progression of periodontitis, pregnancy, history of diabetes mellitus, 
smoking, or consumption of antibiotics within six months prior to examination were excluded from 
the present study. Each patient was subjected to a full periodontal status check by two calibrated 
operators. The diagnoses of periodontitis and healthy periodontal condition were confirmed based on 
the 2017 classification of periodontal diseases [15]. Teeth with 4-5 mm pocket depth were included 
in the present study.  
 
Quantitative PCR (qPCR) 
Gingival crevicular fluid (GCF) samples from up to three teeth with a 4-5 mm pocket depth 
were collected from each patient using sterile #30 absorbent paper points for 30 seconds [24], which 
were placed in 1.5 mL microfuge tubes with 300 µL Tris-EDTA buffer and stored in -80°C until use. 
Following collection of baseline samples, the SRP procedure was performed in all subjects. The GCF 
samples were collected three subsequent times (7, 14, and 28 days following SRP) from subjects with 
periodontitis, but only once for healthy control subjects. 
The mRNA was extracted from the samples using GENEzol™ Reagent (Geneaid Biotech 
Ltd., New Taipei City, Taiwan), and cDNA was synthesized using ReverTra-Ace® (Toyobo Inc., 
Osaka, Japan). All procedures were performed according to the manufacturers’ instructions. 
qPCR was performed using the Applied Biosystems StepOne™ Real-Time PCR system and 
the SensiMix™ SYBR Hi-ROX Kit as a master mix. Primers for OPN were: forward, 5’–TTG CAG 
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CCT TCT CAG CCA A–3’ and reverse, 5’–GGA GGC AAA AGC AAA TCA CTG–3’ [25]. The 
pre-denaturation temperature was 95°C for 3 minutes, followed by 50 cycles of 95°C for 10 seconds, 
60°C for 15 seconds, and 72°C for 10 seconds [26]. β-actin was used as the internal control: forward, 
5’ - TAA TGT CAC GCA CGA TTT CCC–3’ and reverse, 5’ - TCA CCG AGC GCG GCT–3’ using 
the following protocol: 50°C for 2 minutes and 95°C for 10 minutes for the pre-denaturation 
temperatures, followed by 45 cycles of 95°C for 15 seconds and 60°C for 1 minute [27]. qPCR was 
performed in duplicate for each sample. Melting curve analysis was carried out after the end of the 
cycle. The expression levels were estimated using the 2-ΔΔCT method [28,29], and the relative 
expression of OPN was normalized to β-actin. 
 
Statistical Analysis 
The difference between baseline and 28 days following SRP was assessed using Wilcoxon 
analysis, while differences among all study groups (baseline, 7, 14, and 28 days following SRP) were 
analyzed using the Friedman test. Spearman’s correlation test was performed between OPN mRNA 
expression levels and the modified gingival index (MGI). All statistical analysis was performed with 
a 95% confidence interval (CI) using SPSS® version 23. 
 
Ethical Aspects 
All subjects agreed to participate in this research and signed a written informed consent. The 
study protocol was approved by the Ethical Committee of the Faculty of Dentistry, Universitas  
Indonesia (Protocol No. 090230218). 
 
Results 
The characteristics of the subjects are presented in Table 1. The mean age of the subjects 
with periodontitis was 47.25 years old, while that of the healthy subjects was 29.67 years old. Males 
accounted for 75% of the subjects with periodontitis and 66.67% of the healthy subjects. 
 
Table 1. Distribution of patients with periodontitis and healthy subjects. 
Variables Periodontitis Healthy 
Age (Years) 47.25 (± 7.13) 29.67 (± 0.57) 
Sex N (%) N (%) 
Male 3 (75%) 2 (66.67%) 
Female 1 (25%) 1 (33.33%) 
 
The 2-ΔΔCt method was used to analyze the relative OPN mRNA expression data between 
baseline and 28 days following treatment, and also among all groups (baseline, 7, 14, and 28 days 
following SRP). The Wilcoxon test comparing the relative OPN expression levels between baseline 
and 28 days following treatment showed no statistically significant difference (p=0.068). The 
Friedman test also showed no significant differences in the relative OPN expression levels among 
the four groups (p=0.308; Table 2). Spearman’s correlation test between relative OPN expression 
levels and the modified gingival index (MGI) showed no correlation (r=0.087, p=0.749; Figure 1). 
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Table 2. Comparison of the relative OPN mRNA expression levels among subjects with periodontitis. 
Fold Gene Expression of OPN Median (Minimum-Maximum) p-value 
Baseline 2.482 (1.597–10.978) 0.308 
7 Days After SRP 3.955 (0.056–8.122)  
14 Days After SRP 1.429 (0.058–3.331)  
28 Days After SRP 0.441 (0.009–0.792)  
Friedman test. 
 
 
Figure 1. Correlation between relative OPN mRNA expression levels and the MGI. The scatter plot 
shows a very weak positive correlation, but there was no significant difference between relative OPN 
mRNA expression level and the MGI among baseline and 7, 14, and 28 days following treatment. 
 
There was a decreasing trend in OPN mRNA expression levels from baseline to 7, 14, and 28 
days following SRP as measured by q-PCR (Figure 2), but there were no statistically significant 
differences among any of the four groups. Spearman’s correlation showed no correlation between 
relative OPN mRNA expression levels and MGI as a clinical parameter. 
 
 
Figure 2. Comparison of relative OPN mRNA expression levels. The overall OPN mRNA expression in 
subjects with periodontitis relative to the healthy control subjects was 3.202 at baseline, and 1.573 on 
day 7, 0.509 on day 14, and 0.168 on day 28 following treatment. The relative expression of OPN was 
highest at baseline and gradually decreased 7, 14, and 28 days following treatment. 
Baseline 7 days 14 days 28 days 
OPN 3,202992618 1,573828171 0,509085036 0,168891829 
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Discussion 
The present study examined the relative osteopontin (OPN) mRNA expression levels in the 
GCF from teeth of subjects with periodontitis who presented with inflammation of the gingiva and a 
pocket depth of 4-5 mm prior to and following scaling and root planing (SRP) treatment. 
As previously described, MGI was also used as one of the clinical parameters to confirm the 
effect of initial periodontal therapy (SRP) and resulted in a significant correlation of MGI and OPN 
on all groups (healthy, gingivitis, periodontitis) after SRP [12]. Although the present study did not 
succeed to give significant results, but the tendency of MGI and OPN level to correlate was 
reported. 
Previous studies showed a significant difference between healthy and diseased subjects 
[8,12,30]. The present study also recognized higher OPN mRNA expression levels at baseline in 
subjects with periodontitis relative to healthy subjects, which is in accordance with previous studies. 
Although no significant difference was found in the present study, the tendency of OPN to 
decrease after SRP indicated the healing process of the periodontium followed by decreasing number 
of osteoclasts which was reported on the previous study [13]. During the first month as the early 
stage of cellular response, OPN was found to tend to decrease based on the present study. This result 
might be considered as a sign of periodontal healing and discontinuance of bone destruction process 
of the disease that was marked on the first month after therapy [13]. 
It should be noted that previous studies have used ELISA to determine OPN protein 
concentration [8,12,30], while the present study used qPCR to detect OPN mRNA. Generally, 
qPCR has the disadvantage that mRNA expression levels do not always reflect actual protein 
expression levels; moreover, the highly sensitive system may not reach the detection threshold [31]. 
Previous studies have also been performed in a minimum of 45 subjects, while only seven subjects 
were included in the present study; the small number of subjects may have influenced the normality 
of the data and the outcome of the statistical analysis. The present study analyzed the OPN levels on 
day 7, 14, and 28 following SRP treatment, while other authors evaluated the OPN levels eight 
weeks following treatment [12,30]. The collection timing in the present study may have been 
another possible cause of the insignificant difference in the results. 
Despite these limitations, the present study shows higher OPN mRNA expression levels 
relative to the healthy subjects, and the tendency to decrease gradually following SRP treatment (7, 
14, 28 days) as the MGI decreases; however, neither the difference nor the correlation was 
statistically significant. 
 
Conclusion 
Osteopontin mRNA expression levels in the GCF of subjects with periodontitis were higher 
than those in healthy subjects. The initial periodontal therapy of SRP in subjects with periodontitis 
reduces OPN levels in the GCF as the MGI decreases; however, there was no statistical difference 
between baseline and any of the post-therapy groups. The decrease in OPN levels is in accordance 
with the decrease in MGI as a periodontal healing clinical parameter. 
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OPN mRNA expression levels can be used as a biomarker of periodontal healing or 
periodontitis progression that was confirmed on present study by the tendency of decreasing OPN 
level after SRP on early stage of cellular response that might lead to the decrease osteoclasts number 
and disease cessation. Further studies are required with a larger sample size and a longer 
observation period to determine OPN mRNA expression levels in periodontitis on every stage of 
bone remodeling, and to confirm the efficacy and success of initial periodontal therapy on periodontal 
healing. 
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